Should China be closed forever? A Preventive Medicine golden jubilee commentary.

Authors:
Liu S; Wang MZ; Mokdad AH.

Journal:
Prev Med

Publication Year: 2022

DOI:
10.1016/j.ypmed.2022.107102

PMCID:
PMC9162881

PMID:
35661663

Journal Information

Full Title: Prev Med

Abbreviation: Prev Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Public Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest Dr. Liu reports consulting payments and honoraria or promises of the same for scientific presentations or reviews at numerous venues, including but not limited to Barilla, Johns Hopkins University, Fred Hutchinson Cancer Center, Harvard University, University of Buffalo, Guangdong General Hospital, Fuwai Hospital, and Chinese Academy of Medical Sciences, and the National Institutes of Health. He is also a member of the Data Safety and Monitoring Board for several trials, including the SELECT Trial -Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity sponsored by Novo Nordisk and a trial of pulmonary hypertension in diabetes patients sponsored by at Massachusetts General Hospital. He receives royalties from UpToDate. Dr. Liu receives an honorarium from the American Society for Nutrition for his duties as Associate Editor."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025